GNA Biosolutions GmbH, a German molecular diagnostics company, has secured $13.5 million in Series C financing. The investors included GreyBird Ventures, Occident, Wachtumsfonds Bayern, SHS Gesellschaft für Beteiligungsmanagement, Robert Bosch Venture Capital, UVC Partners, Mey Capital Matrix, KfW and btov Partners.
Source: Press Release
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.